Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End Stage Renal Disease: a Randomized Crossover Study
Phase 4
Completed
- Conditions
- Plasma glucoseHypoglycemiaInsulinEnd stage renal diseaseType 2 diabetesInsulinHemodialysisGlycemic controlType 2 diabetes (T2DM)
- Registration Number
- TCTR20180724002
- Lead Sponsor
- Phramongkutklao Hospital and College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
Inclusion criteria comprised being 18 years or older, diagnosis of T2DM, on hemodialysis three sessions weekly and for at least three months, stable insulin dosage for at least three months and stable glycemic treatment with HbA1c<8% for at least three months
Exclusion Criteria
Exclusion criteria included diagnosis of type 1 diabetes, pregnancy, active malignancy, being physically-challenged, active or chronic infection within three months of starting the study and symptomatic hypo- or hyperglycemia within three months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method fasting plasma glucose 8 weeks biochemistry test
- Secondary Outcome Measures
Name Time Method hypoglycemic symptoms 8 weeks clinical assessment and plasma glucose